Repligen (RGEN) revenue breakdown
By product, Product Revenue is the largest at 100% of fiscal 2025 revenue, growing 23% a year over 8 years.
Revenue by product
Fiscal years, as Repligen reports them in its 10-K filings; fiscal 2025 total $738M.
| Products | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | — | $141M | $194M | $270M | $366M | $670M | $801M | $632M | $634M | $738M | 100% |
| Royalty and other revenue | — | $147,000 | $141,000 | $148,000 | $124,000 | $215,000 | $353,000 | $383,000 | $261,000 | $296,000 | 0% |
| Protein products | $55M | — | — | — | — | — | — | — | — | — | — |
| Chromatography products | $30M | — | — | — | — | — | — | — | — | — | — |
| Filtration products | $20M | — | — | — | — | — | — | — | — | — | — |
| Other | $431,000 | — | — | — | — | — | — | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for RGEN.
Open RGEN in InvestinglyQuestions
Where does Repligen make its money?
In fiscal 2025, by product: Product Revenue $738M, Royalty and other revenue $296,000.
From Repligen's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.